Key result
Brachial artery flow-mediated vasodilation was significantly decreased in patients with type 2 diabetes compared to healthy controls, and in severe diabetic retinopathy compared to no retinopathy.
Why the study?
Is the severity of diabetic retinopathy associated with systemic endothelial dysfunction as measured by flow-mediated vasodilation in patients with type 2 diabetes mellitus?
Cross-Sectional (n=95)
Is the severity of diabetic retinopathy associated with systemic endothelial dysfunction as measured by flow-mediated vasodilation in patients with type 2 diabetes mellitus?
Systemic endothelial dysfunction, as measured by impaired flow-mediated vasodilation, is significantly associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes.
Impaired FMD in severe DR may flag broader vascular risk; hypothesis-generating and should not yet change practice.
OBJECTIVE: Retinal endothelial dysfunction is a key in the etiogenesis of diabetic retinopathy (DR), in patients with type 2 diabetes mellitus (DM). Brachial artery flow-mediated vasodilation (FMD) is a marker of endothelial function associated with production of endogenous nitric oxide. Using FMD, we investigated the relationship between macrovascular function and DR. METHODS: We studied 74 patients with type 2 DM, including non-DR (NDR) (n = 30); mild nonproliferative DR (NPDR) (n = 16); moderate NPDR (n = 10); severe NPDR (n = 10); and proliferative DR (PDR) (n = 8); and 21 age-matched controls. We measured FMD in each group. Retinal blood flow and pulsatility ratios were measured using laser Doppler velocimetry. RESULTS: FMD decreased significantly in patients with DM compared with healthy control subjects. No significant differences were found in FMD among the NDR, mild NPDR, and moderate NPDR groups. FMD decreased significantly in the severe NPDR and PDR groups compared with the NDR group. FMD was significantly and negatively correlated with duration of DM and pulsatility ratio. CONCLUSION: Systemic endothelial dysfunction appears to be associated with DR and vascular abnormalities in patients with type 2 DM.
No takes yet. Share an insight, caveat, or question.
Sogawa et al. (2012) conducted a cross-sectional in Type 2 diabetes mellitus (n=95). Diabetic retinopathy vs. Healthy controls and patients without diabetic retinopathy was evaluated on Brachial artery flow-mediated vasodilation (FMD). Brachial artery flow-mediated vasodilation was significantly decreased in patients with type 2 diabetes compared to healthy controls, and in severe diabetic retinopathy compared to no retinopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: